Latest Personal Injury Law News

Cheaper biotech drugs to come to U.S. as Novartis gets FDA approval
Sunday March 08th 2015, 7:02 am Filed under Lipitor lawsuit

(c) 2015, Bloomberg News. WASHINGTON — Americans are poised to gain access to cheaper therapies for serious ailments from cancer to arthritis with Friday's approval of the first biosimilar in the U.S., Novartis' version of Amgen's Neupogen. [News Source]